{"id":"W1615450578","doi":"","title":"CIMAvax-EGF: A novel therapeutic vaccine for advanced lung cancer","year":2009,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Clinical trial; Lung cancer; Medicine; Negotiation; Product (mathematics); Quality (philosophy); Immunogenicity; Agency (philosophy); Biosimilar; Business; Oncology; Political science; Internal medicine; Immunology; Immune system; Sociology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006125669,0.0004244559,0.0002826241,0.0005540646,0.000297061,0.0009584407,0.0003222976,0.0007992575,0.002480499],"category_scores_gemma":[0.0003485949,0.00009661992,0.0003633588,0.0002898371,0.0004173425,0.0005503668,0.0005238486,0.001242775,0.0004868869],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001170518,"about_ca_system_score_gemma":0.001091026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002076582,"about_ca_topic_score_gemma":0.001542741,"domain_scores_codex":[0.9997268,0.00006185378,0.00001007369,0.00004652726,0.00009335493,0.00006130891],"domain_scores_gemma":[0.9998999,0.00001789186,0.00002210859,0.000006626437,0.00002104881,0.0000324693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001377277,0.0006810646,0.001465329,0.001336404,0.00006728832,0.001304799,0.000264452,0.002017972,0.7140265,0.01291158,0.006425511,0.2581218],"study_design_scores_gemma":[0.000437187,0.004981463,0.007393803,0.0003224882,0.0001760723,0.004139711,0.0002443915,0.003384894,0.5473725,0.002031413,0.4294493,0.00006687552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7599018,0.1243435,0.03284783,0.006939237,0.002336081,0.001555782,0.001055214,0.0005220604,0.07049846],"genre_scores_gemma":[0.9138284,0.0287936,0.01796849,0.001171358,0.0002789275,0.00046104,0.001085467,0.0000717979,0.03634103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002480499,"threshold_uncertainty_score":0.008492708,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1401483828248797,"score_gpt":0.5202841043855145,"score_spread":0.3801357215606348,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}